Literature DB >> 28643526

Association between cotinine-verified smoking status and hypertension in 167,868 Korean adults.

Byung Jin Kim1, Ji Min Han1, Jung Gyu Kang2, Bum Soo Kim1, Jin Ho Kang1.   

Abstract

PURPOSE: Previous studies showed inconsistent results concerning the relationship between chronic smoking and blood pressure. Most of the studies involved self-reported smoking status. This study was performed to evaluate the association of urinary cotinine or self-reported smoking status with hypertension and blood pressure in Korean adults.
MATERIALS AND METHODS: Among individuals enrolled in the Kangbuk Samsung Health Study and Kangbuk Samsung Cohort Study, 167,868 participants (men, 55.7%; age, 37.5 ± 6.9 years) between 2011 and 2013 who had urinary cotinine measurements were included. Individuals with urinary cotinine levels ≥50 ng/mL were defined as cotinine-verified current smokers.
RESULTS: The prevalence of hypertension and cotinine-verified current smokers in the overall population was 6.8% and 22.7%, respectively (10.0% in men and 2.8% in women for hypertension: 37.7% in men and 3.9% in women for cotinine-verified current smokers). In a multivariate regression analysis adjusted for age, sex, body mass index, waist circumference, alcohol drinking, vigorous exercise, and diabetes, cotinine-verified current smoking was associated with lower prevalence of hypertension compared with cotinine-verified never smoking (OR[95% CI], 0.79 [0.75, 0.84]). Log-transformed cotinine levels and unobserved smoking were negatively associated with hypertension, respectively (0.96 [0.96, 0.97] and 0.55 [0.39, 0.79]). In a multivariate linear regression analysis, the cotinine-verified current smoking was inversely associated with systolic and diastolic blood pressure (BP) (regression coefficient[95% CI], -1.23[-1.39, -1.07] for systolic BP and -0.71 [-0.84, -0.58] for diastolic BP). In subgroup analyses according to sex, the inverse associations between cotinine-verified current smoking and hypertension were observed only in men.
CONCLUSIONS: This large observational study showed that cotinine-verified current smoking and unobserved smoking were inversely associated with hypertension in Korean adults, especially only in men.

Entities:  

Keywords:  Smoking; blood pressure; cigarette smoke; cotinine; hypertension; nicotine

Mesh:

Substances:

Year:  2017        PMID: 28643526     DOI: 10.1080/08037051.2017.1344539

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  5 in total

1.  Association between Secondhand Smoke Exposure and Hypertension in 106,268 Korean Self-Reported Never-Smokers Verified by Cotinine.

Authors:  Byung Jin Kim; Jeong Gyu Kang; Ji Hye Kim; Dae Chul Seo; Ki Chul Sung; Bum Soo Kim; Jin Ho Kang
Journal:  J Clin Med       Date:  2019-08-16       Impact factor: 4.241

2.  BMI modified the association of current smoking with the incidence of hypertension in Chinese population: a 22-year cohort study.

Authors:  Feifei Yao; Wenfeng Liu; Rencheng Zhao; Guangxiao Li; Xiaojuan Huang; Yongjie Chen
Journal:  BMC Public Health       Date:  2020-03-06       Impact factor: 3.295

3.  Angiotensin II Type I Receptor Antagonism Attenuates Nicotine-Induced Cardiac Remodeling, Dysfunction, and Aggravation of Myocardial Ischemia-Reperfusion Injury in Rats.

Authors:  Anand Ramalingam; Siti Balkis Budin; Norsyahida Mohd Fauzi; Rebecca H Ritchie; Satirah Zainalabidin
Journal:  Front Pharmacol       Date:  2019-12-12       Impact factor: 5.810

4.  Factors Associated with Hypertension Among Men in Darkhan-Uul Province, Mongolia: A Cross-Sectional Study.

Authors:  Naoko Hikita; Megumi Haruna; Masayo Matsuzaki; Emi Sasagawa; Minoru Murata; Ariunaa Yura; Otgontogoo Oidovsuren
Journal:  Asian Pac Isl Nurs J       Date:  2020

5.  Association between cotinine-verified smoking status and moderately increased albuminuria in the middle-aged and older population in Korea: A nationwide population-based study.

Authors:  Yeonjoo Choi; Joo-Hyun Park; Do-Hoon Kim; Hyun Jin Kim; Euijung Suh; Ki-Hoon Kim; Jae Joon Ahn; Gyu-Na Lee; Jin-Hyung Jung; Kyungdo Han; You-Na Shin
Journal:  PLoS One       Date:  2021-02-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.